Study of KN026 Combined With KN046 in Patients With Locally Advanced HER2-positive Solid Tumors
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
This is an open-label, phase II，multi-center study to evaluate the efficacy, safety and
tolerability of KN026 in combination with KN046 in subjects with HER2-positive solid tumors.